Cargando…
How Well Do Results From Randomized Clinical Trials and/or Recommendations for Implantable Cardioverter‐Defibrillator Programming Diffuse Into Clinical Practice?: Translation Assessed in a National Cohort of Patients With Implantable Cardioverter‐Defibrillators (ALTITUDE)
BACKGROUND: Inappropriate implantable cardioverter‐defibrillator programming can be detrimental. Whether trials/recommendations informing best implantable cardioverter‐defibrillator programming (high‐rate cutoff and/or extended duration of detection) influence practice is unknown. METHODS AND RESULT...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405582/ https://www.ncbi.nlm.nih.gov/pubmed/30712432 http://dx.doi.org/10.1161/JAHA.117.007392 |
_version_ | 1783401104520773632 |
---|---|
author | Varma, Niraj Jones, Paul Wold, Nicholas Cronin, Edmond Stein, Kenneth |
author_facet | Varma, Niraj Jones, Paul Wold, Nicholas Cronin, Edmond Stein, Kenneth |
author_sort | Varma, Niraj |
collection | PubMed |
description | BACKGROUND: Inappropriate implantable cardioverter‐defibrillator programming can be detrimental. Whether trials/recommendations informing best implantable cardioverter‐defibrillator programming (high‐rate cutoff and/or extended duration of detection) influence practice is unknown. METHODS AND RESULTS: We measured reaction to publication of MADIT‐RIT (Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy; 2012) and the Consensus Statement (2015) providing generic programming parameters, in a national cohort of implantable cardioverter‐defibrillator recipients, using the ALTITUDE database (Boston Scientific). Yearly changes in programmed parameters to either trial‐specified or class 1 recommended parameters (≥185 beats per minute or delay ≥6 seconds) were assessed in parallel. From 2008 to 2017, 232 982 patients (aged 67±13 years; 28% women) were analyzed. Prevalence of MADIT‐RIT–specific settings before publication was <1%, increasing to 13.6% in the year following. Thereafter, this increased by <6% over 5 years. Among preexisting implants (91 171), most patients (58 739 [64.4%]) underwent at least 1 in‐person device reprogramming after trial publication, but <2% were reprogrammed to MADIT‐RIT settings. Notably, prevalence of programming to ≥185 beats per minute or delay ≥6 seconds was increased by MADIT‐RIT (57.4% in 2013 versus 40.2% at baseline), but the following publication of recommendations had minor incremental effect (73.2% in 2016 versus 70.8% in 2015). High‐rate cutoff programming was favored almost 2‐fold compared with extended duration throughout the test period. Practice changes demonstrated large interhospital and interstate variations. CONCLUSIONS: Trial publication had an immediate effect during 1 year postpublication, but absolute penetration was low, and amplified little with time. Consensus recommendations had a negligible effect. However, generic programming was exercised more widely, and increased after trial publication, but not following recommendations. |
format | Online Article Text |
id | pubmed-6405582 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-64055822019-03-21 How Well Do Results From Randomized Clinical Trials and/or Recommendations for Implantable Cardioverter‐Defibrillator Programming Diffuse Into Clinical Practice?: Translation Assessed in a National Cohort of Patients With Implantable Cardioverter‐Defibrillators (ALTITUDE) Varma, Niraj Jones, Paul Wold, Nicholas Cronin, Edmond Stein, Kenneth J Am Heart Assoc Original Research BACKGROUND: Inappropriate implantable cardioverter‐defibrillator programming can be detrimental. Whether trials/recommendations informing best implantable cardioverter‐defibrillator programming (high‐rate cutoff and/or extended duration of detection) influence practice is unknown. METHODS AND RESULTS: We measured reaction to publication of MADIT‐RIT (Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy; 2012) and the Consensus Statement (2015) providing generic programming parameters, in a national cohort of implantable cardioverter‐defibrillator recipients, using the ALTITUDE database (Boston Scientific). Yearly changes in programmed parameters to either trial‐specified or class 1 recommended parameters (≥185 beats per minute or delay ≥6 seconds) were assessed in parallel. From 2008 to 2017, 232 982 patients (aged 67±13 years; 28% women) were analyzed. Prevalence of MADIT‐RIT–specific settings before publication was <1%, increasing to 13.6% in the year following. Thereafter, this increased by <6% over 5 years. Among preexisting implants (91 171), most patients (58 739 [64.4%]) underwent at least 1 in‐person device reprogramming after trial publication, but <2% were reprogrammed to MADIT‐RIT settings. Notably, prevalence of programming to ≥185 beats per minute or delay ≥6 seconds was increased by MADIT‐RIT (57.4% in 2013 versus 40.2% at baseline), but the following publication of recommendations had minor incremental effect (73.2% in 2016 versus 70.8% in 2015). High‐rate cutoff programming was favored almost 2‐fold compared with extended duration throughout the test period. Practice changes demonstrated large interhospital and interstate variations. CONCLUSIONS: Trial publication had an immediate effect during 1 year postpublication, but absolute penetration was low, and amplified little with time. Consensus recommendations had a negligible effect. However, generic programming was exercised more widely, and increased after trial publication, but not following recommendations. John Wiley and Sons Inc. 2019-02-03 /pmc/articles/PMC6405582/ /pubmed/30712432 http://dx.doi.org/10.1161/JAHA.117.007392 Text en © 2019 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research Varma, Niraj Jones, Paul Wold, Nicholas Cronin, Edmond Stein, Kenneth How Well Do Results From Randomized Clinical Trials and/or Recommendations for Implantable Cardioverter‐Defibrillator Programming Diffuse Into Clinical Practice?: Translation Assessed in a National Cohort of Patients With Implantable Cardioverter‐Defibrillators (ALTITUDE) |
title | How Well Do Results From Randomized Clinical Trials and/or Recommendations for Implantable Cardioverter‐Defibrillator Programming Diffuse Into Clinical Practice?: Translation Assessed in a National Cohort of Patients With Implantable Cardioverter‐Defibrillators (ALTITUDE) |
title_full | How Well Do Results From Randomized Clinical Trials and/or Recommendations for Implantable Cardioverter‐Defibrillator Programming Diffuse Into Clinical Practice?: Translation Assessed in a National Cohort of Patients With Implantable Cardioverter‐Defibrillators (ALTITUDE) |
title_fullStr | How Well Do Results From Randomized Clinical Trials and/or Recommendations for Implantable Cardioverter‐Defibrillator Programming Diffuse Into Clinical Practice?: Translation Assessed in a National Cohort of Patients With Implantable Cardioverter‐Defibrillators (ALTITUDE) |
title_full_unstemmed | How Well Do Results From Randomized Clinical Trials and/or Recommendations for Implantable Cardioverter‐Defibrillator Programming Diffuse Into Clinical Practice?: Translation Assessed in a National Cohort of Patients With Implantable Cardioverter‐Defibrillators (ALTITUDE) |
title_short | How Well Do Results From Randomized Clinical Trials and/or Recommendations for Implantable Cardioverter‐Defibrillator Programming Diffuse Into Clinical Practice?: Translation Assessed in a National Cohort of Patients With Implantable Cardioverter‐Defibrillators (ALTITUDE) |
title_sort | how well do results from randomized clinical trials and/or recommendations for implantable cardioverter‐defibrillator programming diffuse into clinical practice?: translation assessed in a national cohort of patients with implantable cardioverter‐defibrillators (altitude) |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405582/ https://www.ncbi.nlm.nih.gov/pubmed/30712432 http://dx.doi.org/10.1161/JAHA.117.007392 |
work_keys_str_mv | AT varmaniraj howwelldoresultsfromrandomizedclinicaltrialsandorrecommendationsforimplantablecardioverterdefibrillatorprogrammingdiffuseintoclinicalpracticetranslationassessedinanationalcohortofpatientswithimplantablecardioverterdefibrillatorsaltitude AT jonespaul howwelldoresultsfromrandomizedclinicaltrialsandorrecommendationsforimplantablecardioverterdefibrillatorprogrammingdiffuseintoclinicalpracticetranslationassessedinanationalcohortofpatientswithimplantablecardioverterdefibrillatorsaltitude AT woldnicholas howwelldoresultsfromrandomizedclinicaltrialsandorrecommendationsforimplantablecardioverterdefibrillatorprogrammingdiffuseintoclinicalpracticetranslationassessedinanationalcohortofpatientswithimplantablecardioverterdefibrillatorsaltitude AT croninedmond howwelldoresultsfromrandomizedclinicaltrialsandorrecommendationsforimplantablecardioverterdefibrillatorprogrammingdiffuseintoclinicalpracticetranslationassessedinanationalcohortofpatientswithimplantablecardioverterdefibrillatorsaltitude AT steinkenneth howwelldoresultsfromrandomizedclinicaltrialsandorrecommendationsforimplantablecardioverterdefibrillatorprogrammingdiffuseintoclinicalpracticetranslationassessedinanationalcohortofpatientswithimplantablecardioverterdefibrillatorsaltitude |